A Global Shift from Mortality to Disability in Retinoblastoma: A Secondary Analysis of the 2021 Global Burden of Disease Study (1990–2021)

PURPOSE: To analyze the evolving global burden of retinoblastoma (RB) from 1990 to 2021, focusing on component-specific changes, health inequalities, and future projections. METHODS: Using Global Burden of Disease (GBD) 2021 data, we calculated age-standardized rates for years lived with disability (ASYR), years of life lost (ASYLLR), and age-standardized DALYs rate (ASDR). Trends were evaluated using estimated annual percentage change (EAPC), health inequities using the Slope Index of Inequality (SII) and Concentration Index (CII), and future burden was projected using a Bayesian age-period-cohort (BAPC) model. RESULTS: The global ASDR of RB declined from 4.54 (95% uncertainty interval [UI], 2.60-5.94) to 3.65 (95% UI, 2.21-4.96)(EAPC, -0.42%; 95% CI, -0.53 to -0.31); the ASYR rose from 0.04 (95% UI, 0.03-0.07) to 0.05 (95% UI, 0.03-0.09) (EAPC: 1.35%; 95% CI: 1.13-1.56); and the ASYLLR fell from 4.50 (95% UI, 2.57-5.90) to 3.60 (95% UI, 2.17-4.89) (EAPC: -0.44%; 95% CI, -0.56 to -0.33). The SII decreased from -8.05 (95% confidence interval [CI], -9.11 to -7.00) in 1990 to -5.16 (95% CI, -5.83 to -4.49) in 2021. The CII increased from -0.51 (95% CI, -0.61 to -0.41) to -0.58 (95% CI, -0.67 to -0.48). From 2021 to 2050, ASYR, ASYLLR and ASDR are expected to rise. CONCLUSION: The global RB burden is undergoing an epidemiological transition from mortality to long-term disability. Low-SDI regions continue to bear the highest burden, while global relative inequality is worsening. Future efforts require a dual strategy: strengthening health systems in low-resource settings and prioritizing the growing morbidity and disability burden among survivors.

Authors

Institutions

Publication Details

Journal
Ophthalmic Epidemiology
Published
2026-11-18
DOI
https://doi.org/10.1080/09286586.2026.2764147
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Global Shift from Mortality to Disability in Retinoblastoma: A Secondary Analysis of the 2021 Global Burden of Disease Study (1990–2021)

Yongqing Shao, Guohai Wu, Linbin Zhou, Chaoqun Hua et al.
Ophthalmic Epidemiology
Ocular Oncology and Treatments
article

A Global Shift from Mortality to Disability in Retinoblastoma: A Secondary Analysis of the 2021 Global Burden of Disease Study (1990–2021)

Yongqing Shao, Guohai Wu, Linbin Zhou, Chaoqun Hua, Quanyong Yi, Wai Kit Chu, Xueli Shao, Ivan Kong, Tianyu Wang, Yushi Yin, Weiwei Xie, Xiaojing Cai
article en

Abstract

PURPOSE: To analyze the evolving global burden of retinoblastoma (RB) from 1990 to 2021, focusing on component-specific changes, health inequalities, and future projections. METHODS: Using Global Burden of Disease (GBD) 2021 data, we calculated age-standardized rates for years lived with disability (ASYR), years of life lost (ASYLLR), and age-standardized DALYs rate (ASDR). Trends were evaluated using estimated annual percentage change (EAPC), health inequities using the Slope Index of Inequality (SII) and Concentration Index (CII), and future burden was projected using a Bayesian age-period-cohort (BAPC) model. RESULTS: The global ASDR of RB declined from 4.54 (95% uncertainty interval [UI], 2.60-5.94) to 3.65 (95% UI, 2.21-4.96)(EAPC, -0.42%; 95% CI, -0.53 to -0.31); the ASYR rose from 0.04 (95% UI, 0.03-0.07) to 0.05 (95% UI, 0.03-0.09) (EAPC: 1.35%; 95% CI: 1.13-1.56); and the ASYLLR fell from 4.50 (95% UI, 2.57-5.90) to 3.60 (95% UI, 2.17-4.89) (EAPC: -0.44%; 95% CI, -0.56 to -0.33). The SII decreased from -8.05 (95% confidence interval [CI], -9.11 to -7.00) in 1990 to -5.16 (95% CI, -5.83 to -4.49) in 2021. The CII increased from -0.51 (95% CI, -0.61 to -0.41) to -0.58 (95% CI, -0.67 to -0.48). From 2021 to 2050, ASYR, ASYLLR and ASDR are expected to rise. CONCLUSION: The global RB burden is undergoing an epidemiological transition from mortality to long-term disability. Low-SDI regions continue to bear the highest burden, while global relative inequality is worsening. Future efforts require a dual strategy: strengthening health systems in low-resource settings and prioritizing the growing morbidity and disability burden among survivors.

Ophthalmic Epidemiology
Chinese University of Hong Kong (HK), Wenzhou Medical University (CN), Children's Hospital of Fudan University (CN)
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon